Fu Tsai-Sheng, Chen Wei-Chuan, Wang Ying-Chih, Chang Chia-Wei, Lin Tung-Yi, Wong Chak-Bor
Department of Orthopaedic Surgery, Chang Gung Memorial Hospital, School of Medicine, Chang Gung University, Taoyuan, Taiwan.
Graduate School of Biotechnology and Bioengineering, Yuan Ze University, Taoyuan, Taiwan.
Bone Joint Res. 2023 Dec 6;12(12):722-733. doi: 10.1302/2046-3758.1212.BJR-2023-0013.R1.
Several artificial bone grafts have been developed but fail to achieve anticipated osteogenesis due to their insufficient neovascularization capacity and periosteum support. This study aimed to develop a vascularized bone-periosteum construct (VBPC) to provide better angiogenesis and osteogenesis for bone regeneration.
A total of 24 male New Zealand white rabbits were divided into four groups according to the experimental materials. Allogenic adipose-derived mesenchymal stem cells (AMSCs) were cultured and seeded evenly in the collagen/chitosan sheet to form cell sheet as periosteum. Simultaneously, allogenic AMSCs were seeded onto alginate beads and were cultured to differentiate to endothelial-like cells to form vascularized bone construct (VBC). The cell sheet was wrapped onto VBC to create a vascularized bone-periosteum construct (VBPC). Four different experimental materials - acellular construct, VBC, non-vascularized bone-periosteum construct, and VBPC - were then implanted in bilateral L4-L5 intertransverse space. At 12 weeks post-surgery, the bone-forming capacities were determined by CT, biomechanical testing, histology, and immunohistochemistry staining analyses.
At 12 weeks, the VBPC group significantly increased new bone formation volume compared with the other groups. Biomechanical testing demonstrated higher torque strength in the VBPC group. Notably, the haematoxylin and eosin, Masson's trichrome, and immunohistochemistry-stained histological results revealed that VBPC promoted neovascularization and new bone formation in the spine fusion areas.
The tissue-engineered VBPC showed great capability in promoting angiogenesis and osteogenesis in vivo. It may provide a novel approach to create a superior blood supply and nutritional environment to overcome the deficits of current artificial bone graft substitutes.
已研发出多种人工骨移植材料,但由于其新生血管形成能力和骨膜支持不足,未能实现预期的骨生成。本研究旨在开发一种带血管的骨-骨膜构建体(VBPC),为骨再生提供更好的血管生成和骨生成能力。
根据实验材料将24只雄性新西兰白兔分为四组。培养同种异体脂肪来源间充质干细胞(AMSCs),并将其均匀接种于胶原/壳聚糖片上形成细胞片作为骨膜。同时,将同种异体AMSCs接种到海藻酸钠珠上并培养使其分化为内皮样细胞,形成带血管的骨构建体(VBC)。将细胞片包裹在VBC上,制成带血管的骨-骨膜构建体(VBPC)。然后将四种不同的实验材料——脱细胞构建体、VBC、非带血管的骨-骨膜构建体和VBPC——植入双侧L4-L5椎间孔。术后12周,通过CT、生物力学测试、组织学和免疫组织化学染色分析确定骨形成能力。
术后12周,VBPC组的新骨形成体积与其他组相比显著增加。生物力学测试显示VBPC组的扭矩强度更高。值得注意的是,苏木精-伊红染色、Masson三色染色和免疫组织化学染色的组织学结果显示,VBPC促进了脊柱融合区域的新生血管形成和新骨形成。
组织工程化VBPC在体内具有强大的促进血管生成和骨生成的能力。它可能提供一种新方法,以创造更好的血液供应和营养环境,克服当前人工骨移植替代物的不足。